Translation, cross-cultural adaptation and psychometric evaluation of yoruba version of the short-form 12 health survey
Keywords:
Yoruba SF-12, Cross-Cultural Adaptation, Psychometric Evaluation, Health-related quality of lifeAbstract
Background. Short Form 12 (SF-12) health survey has found its utility in clinical and research settings because of its short length that spares time. Though several translations into other languages do exist there is none available in Yoruba language. Hence, this study’s objective was to culturally adapt and determine the reliability and validity of the Yoruba translated version of the SF-12.
Methods. Forward and backward translations of SF-12 into Yoruba version of SF-12 (Y-SF-12) were done using the International Quality of Life Assessment Project Guidelines. Healthy participants were assessed using both English and Yoruba versions of SF-12 for the validation phase, and two weeks later were reassessed with the Y-SF-12 for the reliability phase.
Results. Participants were 225 males and 171 females. The mean scores for each scale range from 73.4 to
86.1, with no gender difference. All scale and domain scores evidenced a negative skew and ranges from -1.79 to -0.62. Concurrent validity (0.879 – 0.938) and convergent validity (0.786 – 0.907) appeared to be good as reflected by their correlation values. The internal consistency of Y-SF-12 was good as Cronbach’s Alpha ranged between 0.899 and 0.968, while the Intraclass Correlation Coefficient (ICC) ranged between 0.775 and 0.949.
Conclusion. This is the first study to assess the psychometric properties of the Y-SF-12. It appears to be valid and may be an appropriate tool for assessing health-related quality of life among Yoruba population. The tool may help to improve the health outcomes of individuals, and redress health inequalities in low and middle-income countries.
References
1. Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34(3): 220-33. doi:
10.1097/00005650-199603000-00003.
2. Patel AR, Lester RT, Marra CA, et al. The validity of the SF-12 and SF-6D instruments in people living with HIV/AIDS in Kenya. Health Qual Life Outcomes 2017; 15(1): 143. doi: 10.1186/ s12955-017-0708-7.
3. Tawiah AK, Al Sayah F, Ohinmaa A, Johnson JA. Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis. Health Qual Life Outcomes 2019; 17(1): 68. doi: 10.1186/ s12955-019-1129-6.
4. Wang X, Guo G, Zhou L, et al. Health-related quality of life in pregnant women living with HIV: a comparison of EQ-5D and SF-12. Health Qual Life Outcomes 2017; 15(1):158. doi: 10.1186/s12955-017-0731-8.
5. Okonkwo OC, Roth DL, Pulley L, Howard G. Confirmatory factor analysis of the validity of the SF-12 for persons with and without a history of stroke. Qual Life Res Int J Qual Life Asp Treat Care Rehabil 2010; 19(9): 1323-31. doi: 10.1007/s11136-010-9691-8.
6. Luo X, George ML, Kakouras I, et al. Reliability, validity, and responsiveness of the short form 12item survey (SF-12) in patients with back pain.
Spine 2003; 28(15): 1739-45. doi: 10.1097/01. BRS.0000083169.58671.96.
7. Campolina AG, Lopez RVM, Nardi EP, Ferraz MB. Quality of life in a sample of Brazilian adults using the generic SF-12 questionnaire. Rev Assoc Medica Bras (1992) 2018; 64(3): 234-42. doi: 10.1590/1806-9282.64.03.234.
8. Kontodimopoulos N, Pappa E, Niakas D, Tountas Y. Validity of SF-12 summary scores in a Greek general population. Health Qual Life Outcomes 2007; 5: 55. doi: 10.1186/1477-7525 -5-55.
9. Larson CO, Schlundt D, Patel K, Beard K, Hargreaves M. Validity of the SF-12 for use in a low-income African American communitybased research initiative (REACH 2010). Prev Chronic Dis 2008; 5(2): A44.
10. Galenkamp H, Stronks K, Mokkink LB, Derks EM. Measurement invariance of the SF-12 among different demographic groups: The HELIUS study. PloS One 2018; 13(9): e0203483. doi: 10.1371/journal.pone.0203483.
11. Gandek B, Ware JE, Aaronson NK, et al. Crossvalidation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51(11): 1171-8. doi: 10.1016/s0895-4356(98)00109-7.
12. Ware JE, Snow KK, Kosinski M, Gandek B; New England Medical Center Hospital Health Institute. SF-36 Health Survey: Manual and Interpretation Guide. Boston MA: Health Institute, New England Medical Center, 1993.
13. Ibrahim AA, Akindele MO, Ganiyu SO, et al. The Hausa 12-item short-form health survey (SF-12): Translation, cross-cultural adaptation and validation in mixed urban and rural Nigerian populations with chronic low back pain. PloS One. 2020;15(5): e0232223. doi: 10.1371/ journal.pone.0232223.
14. Ware JE, Keller SD, Kosinski M. SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales. Boston, MA: Health Institute, New England Medical Center, 1995.
15. Failde I, Medina P, Ramirez C, Arana R. Construct and criterion validity of the SF-12 health questionnaire in patients with acute myocardial infarction and unstable angina. J Eval Clin Pract 2010; 16(3): 569-73. doi: 10.1111/j.1365-2753 .2009.01161.x.
16. Montazeri A, Vahdaninia M, Mousavi SJ, Omidvari S. The Iranian version of 12-item Short Form Health Survey (SF-12): factor structure, internal consistency and construct validity. BMC Public Health 2009; 9: 3 41. doi: 10.1186/14712458-9-341.
17. Younsi M, Chakroun M. Measuring health-related quality of life: psychometric evaluation of the Tunisian version of the SF-12 health survey. Qual Life Res Int J Qual Life Asp Treat Care Rehabil 2014; 23(7): 2047-54. doi: 10.1007/ s11136-014-0641-8.
18. Globe DR, Levin S, Chang TS, Mackenzie PJ, Azen S. Validity of the SF-12 quality of life instrument in patients with retinal diseases. Ophthalmology 2002; 109(10): 1793-8. doi:
10.1016/s0161-6420(02)01124-7.
19. McCarthy ML, Silberstein CE, Atkins EA, Harryman SE, Sponseller PD, Hadley-Miller NA. Comparing reliability and validity of pediatric instruments for measuring health and well-being of children with spastic cerebral palsy. Dev Med Child Neurol 2002; 44(7): 468-76. doi: 10.1017/ s0012162201002377.
20. Mbada CE, Adeogun GA, Ogunlana MO, et al. Translation, cross-cultural adaptation and psychometric evaluation of yoruba version of the short-form 36 health survey. Health Qual Life Outcomes 2015; 13: 141. doi: 10.1186/ s12955-015-0337-y.
21. Wikipedia. Yoruba language. In: Wikipedia, 2020. Available on: https://en.wikipedia.org/w/index. php?title=Yoruba_language&oldid=950990033 [Last accessed: 2020, June 6].
22. Akinpelu AO, Maruf FA, Adegoke BOA. Validation of a Yoruba translation of the World Health Organization’s quality of life scale--short form among stroke survivors in Southwest Nigeria. Afr J Med Med Sci 2006; 35(4): 417-24.
23. Knottnerus P. Multistage and Cluster (Sub)
Sampling. In: Knottnerus P, ed. Sample Survey Theory: Some Pythagorean Perspectives. Springer Series in Statistics. Springer, 2003: 147-87. doi: 10.1007/978-0-387-21764-2_6.
24. Kasiulevičius V, Šapoka V, Filipavičiūtė R. Sample size calculation in epidemiological studies. Gerontologija 2006; 7(4): 225-31.
25. Ware JE, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998; 51(11): 903-12. doi: 10.1016/ s0895-4356(98)00081-x.
26. Ware JE. How to Score Version 2 of the SF-12 Health Survey (with a Supplement Documenting Version 1). Quality Metric Inc: Health Assessment Lab, 2005.
27. Streiner DL, Norman GR, Cairney J. Health Measurement Scales: A Practical Guide to Their Development and Use. 5th ed. Oxford University Press, 2014. Available on: https://oxfordmedicine.com/view/10.1093/ med/9780199685219.001.0001/med-
9780199685219 [Last accessed: 2020, June 6].
28. Allen J, Alpass FM, Stephens CV. The sensitivity of the MOS SF-12 and PROMIS® global summary scores to adverse health events in an older cohort. Qual Life Res Int J Qual Life Asp Treat Care Rehabil 2018; 27(8): 2207-15. doi:10.1007/ s11136-018-1871-y.
29. Norhayati MN, Nik Hazlina NH, Aniza AA. Immediate and long-term relationship between severe maternal morbidity and health-related quality of life: a prospective double cohort comparison study. BMC Public Health 2016; 16. doi: 10.1186/s12889-016-3524-9.
30. Aaronson NK, Acquadro C, Alonso J, et al. International Quality of Life Assessment (IQOLA) Project. Qual Life Res Int J Qual Life Asp Treat Care Rehabil 1992; 1(5): 349-51. doi: 10.1007/ bf00434949.
31. Hopman WM, Towheed T, Anastassiades T, et al. Canadian normative data for the SF-36 health survey. CMAJ Can Med Assoc J 2000; 163(3):
265-71.
32. Tavakol M, Dennick R. Making sense of Cron- 33. Koo TK, Li MY. A Guideline of Selecting and bach’s alpha. Int J Med Educ 2011; 2: 53-5. doi: Reporting Intraclass Correlation Coefficients for 10.5116/ijme.4dfb.8dfd. Reliability Research. J Chiropr Med 2016; 15(2):
155-63. doi: 10.1016/j.jcm.2016.02.012.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.